Gland Pharma

Gland Pharma Limited is a leading Indian generic injectable-focused pharmaceutical company and a major player in the global CDMO (Contract Development and Manufacturing Organization) space. Established in 1978, the company has evolved from a contract manufacturer of small-volume liquid parenterals into one of the world's largest and fastest-growing generic injectable companies, with a presence in over 60 countries including the US, Europe, Canada, and Australia. The company operates primarily under a business-to-business (B2B) model, partnering with global pharmaceutical majors for the development and supply of complex injectables. Its expertise spans a wide range of delivery systems, including liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. Recently, Gland Pharma has strategically expanded into high-growth segments such as GLP-1 receptor agonists (e.g., Liraglutide), biosimilars, and complex technical platforms like dual-chamber bags and pens.